On October 10, 2025, the Sensex rose 329 points to close at 82,501, driven by strong gains in pharmaceutical and financial stocks. Pharma rallied after the U.S. Senate passed the Biosecure Act, expected to benefit Indian drug makers. Financials surged following the government’s approval of a private sector MD at SBI, boosting investor confidence in PSU bank reforms. Analysts noted that these regulatory and governance developments, combined with positive foreign inflows, strengthened overall market sentiment and optimism.